The Scottish Medicines Consortium (SMC) has accepted semaglutide (Wegovy, Novo Nordisk) for use in NHS Scotland to reduce cardiovascular risk in adults with established cardiovascular disease who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results